 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Deciphera Pharmaceuticals Inc. (DCPH)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-01-24 Sale | 2020-01-28 4:13 pm | Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director | 25,000 | $66.13 | $1,653,325 | 0 (Direct) | View |
| 2020-01-22 Sale | 2020-01-24 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 26,999 | $67.18 | $1,813,709 | 17,000 (Direct) | View |
| 2020-01-15 Sale | 2020-01-17 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $65.27 | $981,205 | 0 (Direct) | View |
| 2020-01-07 Sale | 2020-01-09 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 13,931 | $60.1 | $837,308 | 0 (Direct) | View |
| 2020-01-02 Sale | 2020-01-06 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 16,137 | $58.55 | $944,872 | 0 (Direct) | View |
| 2020-01-02 Sale | 2020-01-06 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 125,000 | $57.71 | $7,214,036 | 0 (Direct) | View |
| 2020-01-02 Sale | 2020-01-06 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 12,000 | $57.65 | $691,741 | 0 (Direct) | View |
| 2020-01-02 Sale | 2020-01-06 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 23,542 | $57.67 | $1,357,663 | 0 (Direct) | View |
| 2019-12-23 Sale | 2019-12-26 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 40,000 | $68.21 | $2,728,368 | 0 (Direct) | View |
| 2019-12-12 Sale | 2019-12-13 5:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 31,029 | $60 | $1,861,740 | 35,750 (Indirect Direct) | View |
| 2019-12-12 Sale | 2019-12-13 5:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $60 | $902,040 | 0 (Direct) | View |
| 2019-12-09 Sale | 2019-12-11 4:30 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $55 | $826,870 | 0 (Direct) | View |
| 2019-12-09 Sale | 2019-12-11 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 152,927 | $55 | $8,410,985 | 24,500 (Indirect Direct) | View |
| 2019-12-03 Sale | 2019-12-05 4:20 pm | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $50 | $751,763 | 0 (Direct) | View |
| 2019-11-08 Sale | 2019-11-13 4:59 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 152,927 | $48.01 | $7,342,486 | 24,500 (Indirect Direct) | View |
| 2019-11-01 Sale | 2019-11-05 4:17 pm | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 7,500 | $45.02 | $337,646 | 0 (Direct) | View |
| 2019-11-01 Sale | 2019-11-05 4:16 pm | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 25,000 | $45.07 | $1,126,822 | 0 (Direct) | View |
| 2019-10-28 Sale | 2019-10-30 4:02 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 29,820 | $40 | $1,192,800 | 24,500 (Indirect Direct) | View |
| 2019-10-28 Sale | 2019-10-30 4:01 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 3,750 | $40 | $150,010 | 0 (Direct) | View |
| 2019-09-19 Sale | 2019-09-23 4:03 pm | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 3,000 | $35.56 | $106,688 | 17,000 (Direct) | View |
| 2019-09-11 Sale | 2019-09-13 4:04 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 11,250 | $34.97 | $393,440 | 0 (Direct) | View |
| 2019-09-11 Sale | 2019-09-13 4:03 pm | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 22,500 | $34.97 | $786,832 | 0 (Direct) | View |
| 2019-09-03 Sale | 2019-09-05 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 7,500 | $36.26 | $271,975 | 0 (Direct) | View |
| 2019-08-15 Sale | 2019-08-19 4:35 pm | Deciphera Pharmaceuticals Inc. | DCPH | New Leaf Venture Management III L.L.C. New Leaf Ventures III L.P. New Leaf Biopharma Opportunities I L.P. New Leaf Venture Associates III L.P. New Leaf BPO Associates I L.P. 10% Owner | 350,000 | $36.42 | $12,748,132 | 1,963,258 (Indirect) | View |
| 2019-08-13 Sale | 2019-08-13 7:57 pm | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 22,500 | $40.77 | $917,342 | 0 (Direct) | View |
| 2019-08-13 Sale | 2019-08-13 7:55 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 11,250 | $41.27 | $464,255 | 0 (Direct) | View |
| 2019-08-13 Sale | 2019-08-13 7:52 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 148,107 | $40.92 | $6,060,755 | 66,779 (Indirect Direct) | View |
| 2019-08-13 Sale | 2019-08-13 7:51 pm | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 25,000 | $39.97 | $999,365 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-18 Exercise | 2020-03-20 5:49 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 2,250 | $25.4 | 397,750 (Direct) | View |
| 2020-03-18 Tax Withholding | 2020-03-20 5:49 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 4,494 | $35.78 | 397,750 (Direct) | View |
| 2020-03-18 Tax Withholding | 2020-03-20 5:49 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 1,012 | $36.88 | 397,750 (Direct) | View |
| 2020-03-18 Tax Withholding | 2020-03-20 5:49 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 4,230 | $38.26 | 397,750 (Direct) | View |
| 2020-03-18 Tax Withholding | 2020-03-20 5:49 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 2,164 | $39.22 | 397,750 (Direct) | View |
| 2020-03-18 Tax Withholding | 2020-03-20 5:49 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 520 | $39.98 | 397,750 (Direct) | View |
| 2020-03-18 Option Award | 2020-03-20 5:49 pm | N/A 2029-03-17 | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 2,250 | $25.4 | 397,750 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 7,040 | $0 | 42,190 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 4:10 pm | N/A 2030-02-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 42,190 | $54.87 | 42,190 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 1,760 | $0 | 10,520 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 4:10 pm | N/A 2030-02-17 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 10,520 | $54.87 | 10,520 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 7,040 | $0 | 42,190 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 4:10 pm | N/A 2030-02-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 42,190 | $54.87 | 42,190 (Direct) | View |
| 2020-02-18 Option Award | 2020-02-20 4:10 pm | N/A 2030-02-17 | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 180,000 | $54.87 | 180,000 (Direct) | View |
| 2019-11-25 Option Award | 2020-02-20 4:05 pm | N/A 2029-11-25 | Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director | 23,400 | $48.44 | 23,400 (Direct) | View |
| 2019-12-04 Option Award | 2020-02-20 4:05 pm | N/A 2029-12-03 | Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director | 21,900 | $51.85 | 21,900 (Direct) | View |
| 2020-01-24 Conversion | 2020-01-28 4:13 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director | 25,000 | $3.95 | 0 (Direct) | View |
| 2020-01-24 Option Award | 2020-01-28 4:13 pm | N/A 2026-09-26 | Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director | 25,000 | $3.95 | 0 (Direct) | View |
| 2020-01-22 Exercise | 2020-01-24 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 26,999 | $36.1 | 17,000 (Direct) | View |
| 2020-01-22 Conversion | 2020-01-24 4:10 pm | N/A 2028-09-17 | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 26,999 | $36.1 | 17,000 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-22 4:20 pm | N/A 2026-09-26 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 10,106 | $3.95 | 4,944 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 4:11 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 10,106 | $3.95 | 94,817 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 4:11 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 56,800 | $6.13 | 94,817 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 4:11 pm | N/A 2026-09-26 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 10,106 | $3.95 | 94,817 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 4:11 pm | N/A 2027-06-03 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 56,800 | $6.13 | 94,817 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-17 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 12,023 | $3.95 | 0 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-17 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 3,011 | $3.95 | 0 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-17 4:10 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 12,023 | $3.95 | 0 (Direct) | View |
| 2020-01-15 Exercise | 2020-01-17 4:10 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 3,011 | $3.95 | 0 (Direct) | View |
| 2020-01-07 Exercise | 2020-01-09 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 1,650 | $3.95 | 0 (Direct) | View |
| 2020-01-07 Exercise | 2020-01-09 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 12,281 | $3.95 | 0 (Direct) | View |
| 2020-01-07 Exercise | 2020-01-09 4:10 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 1,650 | $3.95 | 0 (Direct) | View |
| 2020-01-07 Exercise | 2020-01-09 4:10 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 12,281 | $3.95 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 16,137 | $3.95 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 16,137 | $3.95 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 93,578 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 31,422 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 93,578 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 31,422 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 7,641 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 4,359 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 7,641 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 4,359 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 15,553 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 7,989 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 15,553 | $1.89 | 0 (Direct) | View |
| 2020-01-02 Exercise | 2020-01-06 4:15 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 7,989 | $1.89 | 0 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-26 4:05 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 40,000 | $1.89 | 0 (Direct) | View |
| 2019-12-23 Exercise | 2019-12-26 4:05 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 40,000 | $1.89 | 0 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-13 5:00 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $3.95 | 0 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-13 5:00 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $3.95 | 0 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:30 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 3,387 | $3.95 | 0 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:30 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 11,647 | $3.95 | 0 (Direct) | View |
| 2019-12-09 Option Award | 2019-12-11 4:30 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 3,387 | $3.95 | 0 (Direct) | View |
| 2019-12-09 Option Award | 2019-12-11 4:30 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 11,647 | $3.95 | 0 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 30,175 | $1.89 | 24,500 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 28,822 | $1.89 | 24,500 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 93,930 | $1.89 | 24,500 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:10 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 30,175 | $1.89 | 24,500 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:10 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 28,822 | $1.89 | 24,500 (Direct) | View |
| 2019-12-09 Exercise | 2019-12-11 4:10 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 93,930 | $1.89 | 24,500 (Direct) | View |
| 2019-12-04 Option Award | 2019-12-06 4:09 pm | N/A 2029-12-03 | Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director | 24,000 | $51.85 | 24,000 (Direct) | View |
| 2019-12-03 Exercise | 2019-12-05 4:20 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $0 | 0 (Direct) | View |
| 2019-12-03 Option Award | 2019-12-05 4:20 pm | N/A 2026-10-20 | Deciphera Pharmaceuticals Inc. | DCPH | Morl Christopher John Chief Business Officer | 15,034 | $3.95 | 0 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-26 4:45 pm | N/A 2029-11-25 | Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director | 24,000 | $48.44 | 24,000 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-13 4:59 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 9,742 | $1.89 | 24,500 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-13 4:59 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 143,185 | $1.89 | 24,500 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-13 4:59 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 9,742 | $1.89 | 24,500 (Direct) | View |
| 2019-11-08 Exercise | 2019-11-13 4:59 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 143,185 | $1.89 | 24,500 (Direct) | View |
| 2019-11-01 Exercise | 2019-11-05 4:17 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 7,500 | $1.89 | 0 (Direct) | View |
| 2019-11-01 Exercise | 2019-11-05 4:17 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 7,500 | $1.89 | 0 (Direct) | View |
| 2019-11-01 Exercise | 2019-11-05 4:16 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 25,000 | $1.89 | 0 (Direct) | View |
| 2019-11-01 Exercise | 2019-11-05 4:16 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 25,000 | $1.89 | 0 (Direct) | View |
| 2019-10-28 Exercise | 2019-10-30 4:02 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 29,820 | $1.89 | 24,500 (Direct) | View |
| 2019-10-28 Exercise | 2019-10-30 4:02 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 29,820 | $1.89 | 24,500 (Direct) | View |
| 2019-10-28 Exercise | 2019-10-30 4:01 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 3,750 | $1.89 | 0 (Direct) | View |
| 2019-10-28 Exercise | 2019-10-30 4:01 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 3,750 | $1.89 | 0 (Direct) | View |
| 2019-10-15 Option Award | 2019-10-17 4:35 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 35,000 | $0 | 150,000 (Direct) | View |
| 2019-10-15 Option Award | 2019-10-17 4:35 pm | N/A 2029-10-14 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 150,000 | $34.43 | 150,000 (Direct) | View |
| 2019-09-11 Exercise | 2019-09-13 4:04 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 11,250 | $1.89 | 0 (Direct) | View |
| 2019-09-11 Exercise | 2019-09-13 4:04 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 11,250 | $1.89 | 0 (Direct) | View |
| 2019-09-11 Exercise | 2019-09-13 4:03 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 22,500 | $1.89 | 0 (Direct) | View |
| 2019-09-11 Exercise | 2019-09-13 4:03 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 22,500 | $1.89 | 0 (Direct) | View |
| 2019-09-03 Exercise | 2019-09-05 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 7,500 | $1.89 | 0 (Direct) | View |
| 2019-09-03 Exercise | 2019-09-05 4:15 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 7,500 | $1.89 | 0 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-13 7:57 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 22,500 | $1.89 | 0 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-13 7:57 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Taylor Michael Douglas Director | 22,500 | $1.89 | 0 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-13 7:55 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 11,250 | $1.89 | 0 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-13 7:55 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 11,250 | $1.89 | 0 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-13 7:52 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 123,107 | $1.89 | 66,779 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-13 7:52 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 123,107 | $1.89 | 66,779 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-13 7:51 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 25,000 | $1.89 | 0 (Direct) | View |
| 2019-08-13 Exercise | 2019-08-13 7:51 pm | N/A 2025-12-17 | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 25,000 | $1.89 | 0 (Direct) | View |